Correlation Between Tarsus Pharmaceuticals and Evertz Technologies

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Evertz Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Evertz Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Evertz Technologies Limited, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Evertz Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Evertz Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Evertz Technologies.

Diversification Opportunities for Tarsus Pharmaceuticals and Evertz Technologies

-0.25

Correlation Coefficient

Tarsus Pharmaceuticals  Evertz Technologies

Very good diversification

The 3 months correlation between Tarsus and Evertz is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Evertz Technologies Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evertz Technologies and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Evertz Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evertz Technologies has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Evertz Technologies go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Evertz Technologies

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.59 times more return on investment than Evertz Technologies. However, Tarsus Pharmaceuticals is 1.59 times more volatile than Evertz Technologies Limited. It trades about 0.2 of its potential returns per unit of risk. Evertz Technologies Limited is currently generating about -0.1 per unit of risk. If you would invest  4,832  in Tarsus Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of  436.00  from holding Tarsus Pharmaceuticals or generate 9.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.48%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Evertz Technologies Limited

Tarsus Pharmaceuticals

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Evertz Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evertz Technologies Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Evertz Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Tarsus Pharmaceuticals and Evertz Technologies

The main advantage of trading using opposite Tarsus Pharmaceuticals and Evertz Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Evertz Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evertz Technologies will offset losses from the drop in Evertz Technologies' long position.

The idea behind Tarsus Pharmaceuticals and Evertz Technologies Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..